Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

• George Fountzilas ,

  * E-mail: fountzil@auth.gr

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Urania Dafni,

  Affiliation Laboratory of Biostatistics, University of Athens School of Nursing, Athens, Greece

  ⨯
• Mattheos Bobos,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Anna Batistatou,

  Affiliation Department of Pathology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Vassiliki Kotoula,

  Affiliation Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Helen Trihia,

  Affiliation Department of Pathology, Metaxas Cancer Hospital, Piraeus, Greece

  ⨯
• Vassiliki Malamou-Mitsi,

  Affiliation Department of Pathology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Spyros Miliaras,

  Affiliation First Department of Surgery, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Sofia Chrisafi,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Savvas Papadopoulos,

  Affiliation Department of Pathology, “Hygeia” Hospital, Athens, Greece

  ⨯
• Maria Sotiropoulou,

  Affiliation Department of Pathology, “Alexandra” Hospital, Athens, Greece

  ⨯
• Theodoros Filippidis,

  Affiliation “Micromedica” Histopathology Laboratory, Athens, Greece

  ⨯
• Helen Gogas,

  Affiliation First Department of Medicine, “Laiko” General Hospital, University of Athens School of Medicine, Athens, Greece

  ⨯
• Triantafyllia Koletsa,

  Affiliation Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Dimitrios Bafaloukos,

  Affiliation First Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

  ⨯
• Despina Televantou,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Konstantine T. Kalogeras,

  Affiliation Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
• Dimitrios Pectasides,

  Affiliation Second Department of Internal Medicine, Oncology Section, “Hippokration” Hospital, Athens, Greece

  ⨯
• Dimosthenis V. Skarlos,

  Affiliation Second Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

  ⨯
• Angelos Koutras,

  Affiliation Division of Oncology, Department of Medicine, University Hospital, University of Patras School of Medicine, Patras, Greece

  ⨯
•  [ ... ],
• Meletios A. Dimopoulos

  Affiliation Department of Clinical Therapeutics, “Alexandra” Hospital, University of Athens School of Medicine, Athens, Greece

  ⨯
• [ view all ]
• [ view less ]